Date & Time of Session - 1/30/26 - from 12:00 - 1:00PM
Overview
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorder affecting women of child-bearing age. This syndrome is associated with menstrual irregularities, hyperandrogenism, and associated metabolic syndrome which puts patients at higher risk for future cardiovascular disease. With new guidelines and newer agents being investigated for management of these symptoms, pharmacists can play a unique role in identifying appropriate therapy, monitoring, and providing patient education for treatment options.
Objectives
Upon completion of this activity, participants will be able to:
1. Review the pathophysiology and presentation of polycystic ovary syndrome (PCOS)
2. Summarize current guideline recommendations for management of PCOS
3. Discuss pregnancy complications and considerations in patients with PCOS
4. Design a patient-specific treatment plan
Target Audience
Pharmacists, residents, and students
Special Services
If you require special assistance to attend this event, please call Megan Russell at (304) 550-0896.
Speaker:
Gabrielle Flynn, PharmD
PGY2 Ambulatory Care Pharmacy Resident
UK College of Pharmacy - Lexington, Kentucky
- 1.00 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-25-046-L01-P
- 1.00 ParticipationUK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.

Facebook
X
LinkedIn
Forward